Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Return on Assets (2020 - 2025)

Foghorn Therapeutics (FHTX) has 6 years of Return on Assets data on record, last reported at 0.09% in Q3 2025.

  • For Q3 2025, Return on Assets rose 20.0% year-over-year to 0.09%; the TTM value through Sep 2025 reached 0.09%, up 20.0%, while the annual FY2024 figure was 0.3%, 2.0% down from the prior year.
  • Return on Assets reached 0.09% in Q3 2025 per FHTX's latest filing, up from 0.16% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.09% in Q3 2025 and bottomed at 0.48% in Q3 2021.
  • Average Return on Assets over 5 years is 0.28%, with a median of 0.29% recorded in 2021.
  • Peak YoY movement for Return on Assets: grew 24bps in 2022, then decreased -9bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.29% in 2021, then rose by 11bps to 0.26% in 2022, then decreased by -27bps to 0.33% in 2023, then grew by 11bps to 0.29% in 2024, then surged by 69bps to 0.09% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.09% in Q3 2025, 0.16% in Q2 2025, and 0.23% in Q1 2025.